Our team leverages extensive experience across a diverse range of cancer projects.
This provides the critical insights needed to design more effective treatments and create an efficient pathway from research to patient care.
Our Team
We have an experienced team each with more than 20 years of experience in designing immunotherapy solutions for cancer and patient care. For the moment only the founders are listed below.
Wim D’Halleweyn
FounderExperienced business developer having build multiple consulting companies and Algovax is his third cancer treatment venture.
Virgil Schijns
Founder & CSOProf. Dr. Immune Intervention with >100 peer reviewed articles, 4 books and several patents.